Ipamorelin mimics the hormone ghrelin at the growth hormone secretagogue receptor (GHSR-1a) on pituitary cells, triggering a pulse of growth hormone release
The participants were divided into two groups: one group took semaglutide, while the other took a placebo (a pill with no active medicine)
That's the only published clinical data directly addressing this switch
Established cardiovascular findings: The SELECT trial found that semaglutide 2.4 mg reduced major cardiovascular events in adults with overweight or obesity and established cardiovascular disease who did not have diabetes
Later that same month, the FDA expanded its shortage notice, also covering the 5-mg dose of Mounjaro, as well as all but the lowest strength of Zepbound
Also, semaglutide injection may increase the risk of developing tumors of the thyroid gland, including medullary thyroid carcinoma